CD24 and bacterial infectious disease: Mouse sepsis models have provided a possible mechanism for the inhibition of the CD24/Siglec-10 interaction and the resulting immunosuppression through the disruption of CD24 sialyation with the use of recombinant bacterial sialidases; however, this strategy harbors the risk of increasing susceptibility to sepsis secondary to bacterial infection [78].